Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beltangady

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlationW A Newton, E H Soule, A B Hamoudi, et al.
Medical and Pediatric Oncology|January 1, 1987
Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomasW M Crist, R B Raney, A Ragab, et al.
Reviews of Infectious Diseases|July 1, 1990
Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patientsM Rozencweig, C McLaren, M Beltangady, et al.
Cancer|October 15, 1985
Soft tissue sarcomas arising in the retroperitoneal space in children. A report from the Intergroup Rhabdomyosarcoma Study (IRS) CommitteeW M Crist, R B Raney, M Tefft, et al.
Cancer|January 15, 1988
The Intergroup Rhabdomyosarcoma Study-I. A final reportH M Maurer, M Beltangady, E A Gehan, et al.
Medical and Pediatric Oncology|January 1, 1988
Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center)F B Ruymann, H R Maddux, A Ragab, et al.
Journal of the National Cancer Institute|September 6, 1995
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factorA D Seidman, R Portenoy, T J Yao, et al.
Blood|December 15, 1992
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus diseaseL P Schacter, M Rozencweig, M Beltangady, et al.
Cancer|May 1, 1988
Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescentsD M Hays, H Shimada, R B Raney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1993
Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virusC McLaren, M Rozencweig, M Beltangady, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlationW A Newton, E H Soule, A B Hamoudi, et al.
Medical and Pediatric Oncology|January 1, 1987
Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomasW M Crist, R B Raney, A Ragab, et al.
Reviews of Infectious Diseases|July 1, 1990
Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patientsM Rozencweig, C McLaren, M Beltangady, et al.
Cancer|October 15, 1985
Soft tissue sarcomas arising in the retroperitoneal space in children. A report from the Intergroup Rhabdomyosarcoma Study (IRS) CommitteeW M Crist, R B Raney, M Tefft, et al.
Cancer|January 15, 1988
The Intergroup Rhabdomyosarcoma Study-I. A final reportH M Maurer, M Beltangady, E A Gehan, et al.
Medical and Pediatric Oncology|January 1, 1988
Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases. A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children's Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children's Cancer Study Group, and the Pediatric Intergroup Statistical Center)F B Ruymann, H R Maddux, A Ragab, et al.
Journal of the National Cancer Institute|September 6, 1995
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factorA D Seidman, R Portenoy, T J Yao, et al.
Blood|December 15, 1992
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus diseaseL P Schacter, M Rozencweig, M Beltangady, et al.
Cancer|May 1, 1988
Clinical staging and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescentsD M Hays, H Shimada, R B Raney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1993
Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virusC McLaren, M Rozencweig, M Beltangady, et al.
Pageof 3